Robert Finizio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Robert finizio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Robert Finizio Today - Breaking & Trending Today
/PRNewswire/ BioFlorida has announced five new board members who will support the organization s effort to grow the life sciences industry in Florida. "The. ....
Operator Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD first-quarter 2020 financial results conference call. [Operator instructions] I would now like to turn the call over to TherapeuticsMD s vice president of investor relations, Nichol Ochsner. Nichol? Nichol Ochsner Vice President, Investor Relations Good morning, everyone. Thank you for joining today to discuss our first-quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our first-quarter financial results. The press release is available on the company s website therapeuticsmd.com and the Investors and Media section. On today s call from TherapeuticsMD are Chief Executive Officer Robert Finizio, Chief Financial Officer James D Arecca, Chief Commercial Officer Dawn Halkuff, and Chief Strategy and Performance Officer Mitchell Krassan. I would like to remind everyone that certain statements made during this conferenc ....
Search jobs 08-Apr-2021 TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium BOCA RATON, Fla. (BUSINESS WIRE) TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, and Theramex, a dedicated women’s health company, announced that BIJUVE ® has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for use in the United Kingdom and, from the Federal Agency for Medicines and Health Products (FAMHP) for use in Belgium under BIJUVA ®. A “decentralized procedure” (DCP) for the regulatory approval of BIJUVA ....
TherapeuticsMD, Inc.: TherapeuticsMD and Theramex Announce the Approval of BIJUVE Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA in Belgium finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Operator Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD fourth-quarter 2020 financial results conference call. [Operator instructions] I would now like to turn the call over to TherapeuticsMD s Vice President of Investor Relations Nichol Ochsner. Nichol? Nichol Ochsner Vice President, Investor Relations Thank you. Good morning, everyone. Thank you for joining today to discuss our fourth-quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our fourth-quarter financial results. The press release is available on the company s website, therapeuticsmd.com in the investors and media section. On today s call from TherapeuticsMD are Chief Executive Officer Robert Finizio, Chief Financial Officer James D Arecca, Chief Commercial Officer Dawn Halkuff, and Chief Strategy and Performance Officer Mitchell Krassan. I would like to remind everyone that certain statements made during t ....